Literature DB >> 28428637

Surgery: Metabolic surgery: the cutting edge of diabetes care.

Francesco Rubino1, Spyros Panagiotopoulos1.   

Abstract

Entities:  

Mesh：

Year:  2017        PMID： 28428637     DOI： 10.1038/nrgastro.2017.45

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  10 in total

Review 1.  Predictors of remission of diabetes mellitus in severely obese individuals undergoing bariatric surgery: do BMI or procedure choice matter? A meta-analysis.

Authors:  Simona Panunzi; Andrea De Gaetano; Annamaria Carnicelli; Geltrude Mingrone
Journal:  Ann Surg       Date:  2015-03       Impact factor: 12.969

2.  Bariatric Surgery versus Intensive Medical Therapy for Diabetes - 5-Year Outcomes.

Authors:  Philip R Schauer; Deepak L Bhatt; John P Kirwan; Kathy Wolski; Ali Aminian; Stacy A Brethauer; Sankar D Navaneethan; Rishi P Singh; Claire E Pothier; Steven E Nissen; Sangeeta R Kashyap
Journal:  N Engl J Med       Date:  2017-02-16       Impact factor: 91.245

3.  Medical research: Time to think differently about diabetes.

Authors:  Francesco Rubino
Journal:  Nature       Date:  2016-05-26       Impact factor: 49.962

Review 4.  Review of the key results from the Swedish Obese Subjects (SOS) trial - a prospective controlled intervention study of bariatric surgery.

Authors:  L Sjöström
Journal:  J Intern Med       Date:  2013-02-08       Impact factor: 8.989

5.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

6.  Effect of duodenal-jejunal exclusion in a non-obese animal model of type 2 diabetes: a new perspective for an old disease.

Authors:  Francesco Rubino; Jacques Marescaux
Journal:  Ann Surg       Date:  2004-01       Impact factor: 12.969

7.  Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial.

Authors:  Geltrude Mingrone; Simona Panunzi; Andrea De Gaetano; Caterina Guidone; Amerigo Iaconelli; Giuseppe Nanni; Marco Castagneto; Stefan Bornstein; Francesco Rubino
Journal:  Lancet       Date:  2015-09-05       Impact factor: 79.321

8.  Metabolic Surgery in the Treatment Algorithm for Type 2 Diabetes: A Joint Statement by International Diabetes Organizations.

Authors:  Francesco Rubino; David M Nathan; Robert H Eckel; Philip R Schauer; K George M M Alberti; Paul Z Zimmet; Stefano Del Prato; Linong Ji; Shaukat M Sadikot; William H Herman; Stephanie A Amiel; Lee M Kaplan; Gaspar Taroncher-Oldenburg; David E Cummings
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

9.  Mechanisms of Diabetes Improvement Following Bariatric/Metabolic Surgery.

Authors:  Rachel L Batterham; David E Cummings
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112

10.  Bariatric/Metabolic Surgery to Treat Type 2 Diabetes in Patients With a BMI <35 kg/m2.

Authors:  David E Cummings; Ricardo V Cohen
Journal:  Diabetes Care       Date:  2016-06       Impact factor: 19.112
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.